Oxford BioDynamics

OBD is a global biotech company advancing personalized healthcare by developing and commercializing #PrecisionMedicine tests for life-changing diseases.

[Oxford BioDynamics @OxBioDynamics]

🎙️#EpiSwitchPSE featured on Health Uncensored with Dr. Drew.
Urologist @gpohlmanmd discussed how #PSE delivers a clear result with 94% accuracy from a blood draw, bringing clarity to the #prostatecancer diagnostic pathway.
Full story: 🔗https://t.co/HBAWUdvyVE
@94percent_com #OBD

[Oxford BioDynamics @OxBioDynamics]

🇺🇸 #Hiring: Clinical Lab Associate II | Frederick, MD.
Join Oxford BioDynamics' US lab, home of the #EpiSwitchPSE 94% accurate prostate cancer detection test. Apply 👉 https://t.co/RGLgXuhfmh
#OBD #EpiSwitch #BiotechJobs #ClinicalLab @94percent_com

[Oxford BioDynamics @OxBioDynamics]

#EpiSwitchPSE featured on Health Uncensored with Dr. Drew—now on YouTube. The advanced, 94% accurate blood test built to bring clarity to #prostatecancer detection.
▶️ Watch it here: https://t.co/OmuEVNNWtN
@94percent_com @HUwithDrDrew @FoxBusiness @gpohlmanmd #urology #OBD #PSE

[Garrett D Pohlman, M.D. @gpohlmanmd]

Honored to join Dr. Drew this evening (4 PM CST / 5 PM EST) on Fox Business Network’s - Dr. Drew’s Health Uncensored to discuss the evolving landscape of #ProstateCancer screening and detection.

[94percent.com @94percent_com]

This Sunday on @HUwithDrDrew: 3 in 4 raised PSA results aren't #prostatecancer. So what comes next?
—Urologist @gpohlmanmd shares what he's seeing using the breakthrough #EpiSwitchPSE test from @OxBioDynamics #OBD, shown to boost accuracy to 94%. 📺17 May 5pm ET @FoxBusiness #PSE

[94percent.com @94percent_com]

🎬 Go behind the scenes with @gpohlmanmd in the green room ahead of Health Uncensored with Dr Drew on @FoxBusiness. The national conversation on accurate #prostatecancer testing with #EpiSwitchPSE is about to hit prime time.
📺 Sun 17 May, 5pm ET
@HUwithDrDrew @OxBioDynamics #OBD

[Oxford BioDynamics @OxBioDynamics]

Up to 79% of prostate biopsies could be avoided. That's the headline from a #ProstateCancer study using #EpiSwitchPSE testing, presented at #LUGPA2026 by Dr @gpohlmanmd—and 100% of patients chose to take the #PSE when offered. More at: https://t.co/xqB23rCyas
#OBD @94percent_com

[Oxford BioDynamics @OxBioDynamics]

📅 10 days to go.
Board-certified Urologist @gpohlmanmd is joining Health Uncensored with Dr. Drew on @FoxBusiness to discuss #EpiSwitchPSE—the blood test changing accurate #prostatecancer detection.
📺 Tune in Sunday 17 May, 5pm ET.
@HUwithDrDrew @94percent_com #PSE #diagnostics

[Oxford BioDynamics @OxBioDynamics]

What does it take to crack #MECFS? @OxBioDynamics CSO Dr Akoulitchev & @uniofeastanglia Prof Pshezhetskiy joined @finding_genius to discuss our breakthrough EpiSwitch blood test (coming soon).
🎧Listen here: https://t.co/qAraCcrYti
#OBD #EpiSwitch #ChronicFatigue #MillionsMissing

[Finding Genius Podcast @finding_genius]

In this episode, Alexandre Akoulitchev and Dmitry Pshezhetskiy share groundbreaking research on a novel blood test designed to detect biological signatures linked to chronic fatigue.

🎶 https://t.co/L6KRu63WfY

👉Follow both on Linkedin

#ChronicFatigueSyndrome #MECFS #Chronic

[94percent.com @94percent_com]

Congrats to Doctors Studio on surpassing 400+ #EpiSwitchPSE tests! Under Dr Roy's leadership, Doctors Studio has made patient-centered #prostatecancer care a cornerstone of their practice, with #PSE playing a key role in their ProstaGen Method. @OxBioDynamics #OBD @LisbethRoyDO

[94percent.com @94percent_com]

���750,000 people have watched an independent UK doctor unpack how #EpiSwitchPSE changes #prostatecancer detection. In his viral video, he describes it as "270% Better Than PSA." https://t.co/NB2iRwAR6J

Med Man is an independent NHS GP not affiliated with @OxBioDynamics #OBD #PSE

[94percent.com @94percent_com]

Congratulations to Kearney Urology Center PC on surpassing 400+ #EpiSwitchPSE orders — a strong example of real-world clinical adoption by a urology clinic committed to improving #prostatecancer outcomes.
@OxBioDynamics #OBD #PSE #ProstateCancer #Diagnostics @gpohlmanmd

[Oxford BioDynamics @OxBioDynamics]

#Genomics has a problem—Billions spent sequencing. Mountains of data. Yet clinical insights haven't kept pace.
#EpiSwitchOrion transforms your data, powered by a map of how genes are controlled in 3D—Same data. New dimension. Breakthrough insights. #OBD
https://t.co/WW64AoiJJM

[94percent.com @94percent_com]

📣Consultant urologist Mr Winkler shares how the #EpiSwitchPSE is part of #prostatecancer diagnostics at Imperial College Healthcare Private Care, Charing Cross Hospital—a leading prostate cancer centre in London. 🔗https://t.co/NR5avqJpNN
@OxBioDynamics #OBD #PSE #PCAM #urology

[Oxford BioDynamics @OxBioDynamics]

Our Chief Data Officer introduced #EpiSwitchOrion at #PMWC2026—#OBD's groundbreaking platform to unlock clinical value hidden in #genomic data. Orion is powered by a model built on our deep expertise—core regulatory logic in the 'dark genome'. Book a demo: https://t.co/WW64Aojhzk

[94percent.com @94percent_com]

Better triage in #ProstateCancer care:
Identify who needs further evaluation—
spare others unnecessary intervention.

Grateful to partners like Jennifer Wright bringing #EpiSwitchPSE into real-world practice.
#OBD #PSE #Urology #PrecisionMedicine

[94percent.com @94percent_com]

Peer-reviewed physician commentary by urologist @gpohlmanmd—“Reducing Unnecessary Prostate Biopsies Through Real-World Clinical Use of the #EpiSwitchPSE Blood Test”— highlights real-world #PSE use supporting confident patient risk assessment. https://t.co/KxrRDFhkFE
#OBD #urology

[Oxford BioDynamics @OxBioDynamics]

🎬Webinar in 100s — Here’s a highlight reel of key moments from “From Mystery to Measurable: The Science Behind the New #MECFS Blood Test.”
Huge thanks again to Solve ME/CFS (@PlzSolveCFS) for hosting @OxBioDynamics & @uniofeastanglia.
#OBD #EpiSwitch #ChronicFatigue #3Dgenomics